The Biological Significance of Fucose-Based Polysaccharides and Oligosaccharides from the Sea
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 15 March 2026 | Viewed by 11
Special Issue Editor
2. Marine Science Institute, Jeju National University, Jeju 63333, Republic of Korea
Interests: polysaccharides; fucoidans; carrageenans; ulvans; agars; alginic acids; chitins and chitosans; chondroitin sulfates; glucosaminoglycans; marine organism; prevention or improvement of disorders; functionalities; bioactivities; bioavailabilities
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The marine environment is a rich source of fucose-based polysaccharides and oligosaccharides, which are gaining attention for their unique biological activities. These compounds often share structural and functional similarities with Human Milk Oligosaccharides (HMOs), making them valuable as prebiotics and immunomodulators. Importantly, marine-derived fucose-based oligosaccharides offer a sustainable alternative to meet the growing demand in the HMO market.
Furthermore, these marine compounds possess novel bioactivities not found in traditional HMOs, unlocking innovative applications in the fields of functional foods and pharmaceuticals. This Special Issue aims to showcase the latest research findings in this promising area and explore the full potential of marine-derived fucose-based compounds.
Prof. Dr. You-Jin Jeon
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- fucose
- fucoidan
- oligosaccharide
- human milk oligosaccharides (HMOs)
- prebiotic
- probiotic
- synbiotic
- microbiome
- anti-inflammation
- gut health
- brown algae
- holothuria
- fucosylated chondroitin sulfate
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
